(Q47578788)

4 February 2018

title

USP compendial methods for analysis of heparin: chromatographic determination of molecular weight distributions for heparin sodium (English)

1 reference

4 February 2018

1 reference

Barbara Mulloy

1

1 reference

4 February 2018

Alan Heath

2

1 reference

4 February 2018

Zachary Shriver

3

1 reference

4 February 2018

Fabian Jameison

4

1 reference

4 February 2018

Ali Al Hakim

5

1 reference

4 February 2018

Tina S Morris

6

1 reference

4 February 2018

Anita Y Szajek

7

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 August 2014

1 reference

4 February 2018

Analytical and Bioanalytical Chemistry

published in

1 reference

4 February 2018

volume

406

1 reference

4 February 2018

issue

20

1 reference

4 February 2018

page(s)

4815-4823

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1007/s00216-014-7940-3

exact match

0 references

cites work

Structure and physicochemical characterisation of heparin

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

Serglycin--structure and biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

Heparanase affects secretory granule homeostasis of murine mast cells through degrading heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

Structurally informative tandem mass spectrometry of highly sulfated natural and chemoenzymatically synthesized heparin and heparan sulfate glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

Liquid Chromatography/Mass Spectrometry Sequencing Approach for Highly Sulfated Heparin-derived Oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

Improved hydrophilic interaction chromatography LC/MS of heparinoids using a chip with postcolumn makeup flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

Size-exclusion chromatography-a review of calibration methodologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

Determination of molecular weight of heparin by size exclusion chromatography with universal calibration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

Conformation of heparin studied with macromolecular hydrodynamic methods and X-ray scattering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

Semi-rigid solution structures of heparin by constrained X-ray scattering modelling: new insight into heparin-protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

Development and qualification of a size exclusion chromatography coupled with multiangle light scattering method for molecular weight determination of unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

Characterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

The molecular-weight range of mucosal-heparin preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

Molecular profiling and weight determination of heparins and depolymerized heparins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

Molecular weight determination of heparin and dermatan sulfate by size exclusion chromatography with a triple detector array

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

The inhibition of blood coagulation by heparins of different molecular weight is caused by a common functional motif--the C-domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

Unfractionated heparin compared with low-molecular-weight heparin as related to heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

Heparin brand is associated with postsurgical outcomes in children undergoing cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7940-3

10.1007/S00216-014-7940-3

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

24958344

1 reference

4 February 2018